The coactivators attracted to promoters of FXR target genes such as ABCB11 and the epigenetic modifications that occur after ligand binding to FXR have not been completely defined, and it is unknown whether and to what extent these processes are disrupted during cholestasis and contribute to the disease process. Here, NR1H4 is linked to cholestasis.